488
Views
0
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study

ORCID Icon, , , , , , , , , , , , , , , , & show all
Pages 1399-1405 | Received 15 Jun 2017, Accepted 05 Sep 2017, Published online: 03 Oct 2017

References

  • Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337–2344.
  • Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51–60.
  • Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111:4029–4038.
  • Baecklund E, Smedby KE, Sutton L-A, et al. Lymphoma development in patients with autoimmune and inflammatory disorders–what are the driving forces? Semin Cancer Biol. 2014;24:61–70.
  • Fallah M, Liu X, Ji J, et al. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol off J Eur Soc Med Oncol. 2014;25:2025–2030.
  • Jardin F, Lévesque H, Tilly H. Auto-immune manifestations in Non-Hodgkin’s lymphoma. Rev Med Interne. 2005;26:557–571.
  • Jardin F. Development of autoimmunity in lymphoma. Expert Rev Clin Immunol. 2008;4:247–266.
  • Van den Bergh M, Alvarez-Argote J, Panwala AH, et al. Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review. Curr Med Res Opin. 2015;31:1861–1870.
  • Martin DN, Mikhail IS, Landgren O. Autoimmunity and hematologic malignancies: associations and mechanisms. Leuk Lymphoma. 2009;50:541–550.
  • Dührsen U, Augener W, Zwingers T, et al. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol. 1987;67:235–239.
  • Váróczy L, Gergely L, Zeher M, et al. Malignant lymphoma-associated autoimmune diseases – a descriptive epidemiological study. Rheumatol Int. 2002;22:233–237.
  • Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 2007;57:1473–1480.
  • Bareau B, Rey J, Hamidou M, et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica 2010;5:1534–1541.
  • Weltgesundheitsorganisation, Swerdlow SH. International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [… reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25–27, 2007]. 4th ed. Lyon: International Agency for Research on Cancer; 2008. 439 p. (World Health Organization classification of tumours).
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–1588.
  • Zhang X, Loberiza FR, Klein JP, et al. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed. 2007;88:95–101.
  • Royston P, Parmar MKB. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Statist Med. 2011;30:2409–2421.
  • Váróczy L, Páyer E, Kádár Z, et al. Malignant lymphomas and autoimmunity-a single center experience from Hungary. Clin Rheumatol. 2012;31:219–22.
  • Zent CS, Ding W, Schwager SM, et al. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol. 2008;141:615–621.
  • Visco C, Ruggeri M, Laura Evangelista M, et al. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood. 2008;111:1110–1116.
  • Geisler C, Hansen MM. Chronic lymphocytic leukaemia: a test of a proposed new clinical staging system. Scand J Haematol. 1981;27:279–286.
  • Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95:2786–2792.
  • Moreno C, Hodgson K, Ferrer G, et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood. 2010;116:4771–4776.
  • Sallah S, Sigounas G, Vos P, et al. Autoimmune hemolytic anemia in patients with non-Hodgkin’s lymphoma: characteristics and significance. Ann Oncol. 2000;11:1571–1577.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.